Manager/Director, Strategic Labelling & Development

At Glaxo Smith Kline, we are looking for an experienced, highly motivated and organized individual to join our team as Manager/Director of Strategic Labelling & Development. This role is integral to the success of our organization and requires an individual with a deep understanding of the pharmaceutical industry and a passion for developing and implementing innovative solutions.The successful candidate will be a strategic thinker with strong leadership and communication skills, as well as the ability to manage multiple projects simultaneously. We are looking for an individual who is able to develop long-term strategic objectives and lead teams to execute them. A deep understanding of the regulatory environment and global labelling process is essential.The ideal candidate will have a minimum of 5 years' experience in a managerial or director role in a pharmaceutical or related industry, with a degree in a related field. Proven experience in leading teams and developing strategies is a must. The successful candidate will be a self-starter with a strong drive to learn, develop and mentor. A collaborative attitude and the ability to work in a fast-paced environment are also essential.

According to JobzMall, the average salary range for a Manager/Director, Strategic Labelling & Development in Durham, NC, USA is $97,500 to $134,000 per year. This range is based on the salaries of similar positions in the area, as well as the experience and qualifications of the applicant.

The exact salary offered to a particular applicant may be higher or lower than this range, depending on a variety of factors including the employer's budget, the job responsibilities, and the applicant's qualifications and experience.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.